JP Morgan Private Wealth Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,358	Closed	-$747K	–	1830
2020 Q4	$747K	Buy	10,358 +25	+0.2%	+$1.31K	﹤0.01%	1119
2020 Q3	$471K	Buy	10,333 +1,994	+24%	+$83.4K	﹤0.01%	1186
2020 Q2	$377K	Buy	+8,339	New	+$374K	﹤0.01%	1220

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

JP Morgan Private Wealth Advisors's BEAT Position: Q1 2021 in Review

JP Morgan Private Wealth Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 10,358 shares — an estimated $747K sold.

JP Morgan Private Wealth Advisors first reported a position in BEAT in Q2 2020 and held it in 3 quarters. The position peaked at $747K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

JP Morgan Private Wealth Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 10,358 BioTelemetry, Inc. shares in Q1 2021, an estimated $747K.
JP Morgan Private Wealth Advisors first reported a position in BioTelemetry, Inc. in Q2 2020 and held it in 3 quarters.
JP Morgan Private Wealth Advisors's BioTelemetry, Inc. position peaked at $747K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2021, filed 14 May 2021.